2351 - 2360 of 5832 Results
Title
Year
-
OPENTitle: On the Road from Phenotypic Plasticity to Stem Cell TherapyJournal Name: The Journal of NeurosciencePublisher: Society for NeuroscienceVol: 41Issue #: 25Start Page: 5331End Page: 5337Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1523/jneurosci.0340-21.2021Best OA location URL: https://www.jneurosci.org/content/jneuro/41/25/5331.full.pdfCitation Count: 0
-
OPENTitle: Parkinson’s Disease Recognition Using SPECT Image and Interpretable AI: A TutorialJournal Name: IEEE Sensors JournalPublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 21Issue #: 20Start Page: 22304End Page: 22316Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1109/jsen.2021.3077949Best OA location URL: https://arxiv.org/pdf/1908.11199Citation Count: 24
-
OPENTitle: Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X MouseJournal Name: BiomedicinesPublisher: MDPI AGVol: 9Issue #: 5Start Page: 514End Page: 514Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biomedicines9050514Best OA location URL: https://www.mdpi.com/2227-9059/9/5/514/pdf?version=1620466923Citation Count: 6
-
OPENTitle: Scoring Algorithm‐Based Genomic Testing in Dystonia: A Prospective Validation StudyJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1959End Page: 1964Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28614Best OA location URL: https://doi.org/10.1002/mds.28614Citation Count: 12
- Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau2021OPENTitle: Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tauJournal Name: EMBO Molecular MedicinePublisher: Springer Science and Business Media LLCVol: 13Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/emmm.202114022Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/emmm.202114022Citation Count: 136
- Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical research2021OPENTitle: Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical researchJournal Name: TrialsPublisher: Springer Science and Business Media LLCVol: 22Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13063-021-05273-xBest OA location URL: https://trialsjournal.biomedcentral.com/counter/pdf/10.1186/s13063-021-05273-xCitation Count: 25
-
OPENTitle: Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1972End Page: 1978Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28608Best OA location URL: https://europepmc.org/articles/pmc8453505?pdf=renderCitation Count: 18
-
OPENTitle: Genomewide Association Studies of LRRK2 Modifiers of Parkinson's DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 90Issue #: 1Start Page: 76End Page: 88Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/ana.26094Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26094Citation Count: 39
-
OPENTitle: Alzheimer's Disease Alters Oligodendrocytic Glycolytic and Ketolytic Gene ExpressionJournal Name: The FASEB JournalPublisher: WileyVol: 35Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1096/fasebj.2021.35.s1.02461Best OA location URL: https://digitalcommons.wustl.edu/context/oa_4/article/3325/viewcontent/Alzheimer_s___Dementia___2021___Saito___Alzheimer_s_disease_alters_oligodendrocytic_glycolytic_and_ketolytic_gene.pdfCitation Count: 1
-
OPENTitle: Cerebral dopamine neurotrophic factor reduces α-synuclein aggregation and propagation and alleviates behavioral alterations in vivoJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 29Issue #: 9Start Page: 2821End Page: 2840Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ymthe.2021.04.035Best OA location URL: http://www.cell.com/article/S1525001621002495/pdfCitation Count: 33